Insulin-like growth factor I accelerates functional recovery from Achilles tendon injury in a rat model.
We studied the effects of insulin-like growth factor I on Achilles tendon healing in a rat model. Rats were randomized into groups of six each: sham surgery, transection alone, and transection plus growth factor. Postoperatively, rats treated with growth factor had a significantly smaller maximum functional deficit and a decreased time to functional recovery than rats in the untreated groups. Biomechanical testing revealed no significant differences in the measured parameters between the treated and the untreated groups after transection. To study the mechanism of action, six additional animals received an Achilles tendon injection of the inflammatory agent carrageenan alone and six received carrageenan plus growth factor. Rats treated with growth factor did not show the inflammation-induced functional deficit experienced by the control rats. Spectrometric myeloperoxidase assays on the remaining eight rats after Achilles tendon transection demonstrated no significant difference between the untreated and the growth factor-treated groups, indicating a mechanism other than neutrophil recruitment by which the growth factor limits inflammation. Histologic studies were performed on carrageenan-injected rats at postinjection day 2 and on surgically treated rats at postoperative day 15. No gross histologic differences were seen between untreated and growth factor-treated groups. This study demonstrated that via a possible antiinflammatory mechanism, insulin-like growth factor I reduces maximum functional deficit and accelerates recovery after Achilles tendon injury.
Kurtz
C A
CA
Department of Orthopaedic Surgery, Allegheny General Hospital, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania, USA.
Loebig
T G
TG
Anderson
D D
DD
DeMeo
P J
PJ
Campbell
P G
PG
D000125:Achilles Tendon / Q000293:injuries* / Q000473:pathology / Q000502:physiology; D000704:Analysis of Variance; D000818:Animals; D001696:Biomechanical Phenomena; D004195:Disease Models, Animal; D007249:Inflammation / Q000628:therapy; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D008297:Male; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013708:Tendon Injuries / Q000628:therapy*
D007334:Insulin-Like Growth Factor I